Comparing the effect of Miltefosine and Meglumine Antimoniate in the treatment of Cutaneous Leishmaniasis
Medical Journal of South Punjab · 2025
DOI: 10.61581/mjsp.v5i01.375 ↗Abstract
Objective: The study aims to compare the efficacy and safety of meglumine antimoniate and miltefosine in the treatment of cutaneous leishmaniasis in Pakistan. Methodology: This randomized-controlled trial was conducted at the Dermatology Departments of Pak Emirates Military Hospital Rawalpindi, Pakistan, from 10 July 2024 to 9 January 2025. Efficacy was graded on Day 28 as excellent (91-100% improvement), good (75-90%), fair (50-74%), or poor (
EUVIMED